HudsonAlpha, Selwyn Vickers, MD to host public conversation about COVID-19 vaccine confidence


April 21, 2021 (Huntsville, Ala.)  – The HudsonAlpha Institute for Biotechnology will host Vaccine Confidence: A Conversation with Selwyn Vickers, MD, April 26 at 6pm, CT. 

The virtual event is part three of the A Path Forward series, which aims to provide community awareness and education to North Alabama’s minority population about COVID-19’s impact. 

Selwyn Vickers, MD, senior vice president of medicine at the University of Alabama at Birmingham (UAB), will hold an open conversation with attendees to address questions and concerns about the COVID-19 vaccine. 

“Stopping a pandemic requires all the tools we have available, and the vaccine will play a major role in our return to normalcy,” said Vickers. “The risk of severe illness or death from COVID-19 far outweighs the risk of side effects from the vaccine. I look forward to being a part of this panel to address any questions or concerns about the vaccine and the importance of receiving it.”

HudsonAlpha launched A Path Forward to provide broad community awareness and education on issues related to genomic health, testing, health disparity and improved access for minority populations. Part one and two of A Path Forward addressed COVID-19 prevention, variants, community engagement and vaccine mistrust. Click here to watch the recordings. 

This event is free, open to the public and will take place via Zoom. The event will also be simulcast on Alabama A&M’s radio station, WJAB 90.9 FM. Click here to register for the Zoom session. 

Part four of A Path Forward will also discuss COVID-19 vaccine confidence and allocation. For more information, visit HudsonAlpha’s Diversity, Equity and Inclusion website

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and fosters more than 40 diverse biotech companies on campus. To learn more about HudsonAlpha, visit hudsonalpha.org.